Ticker Symbol: NSTM
NovelStem International Corp
Exchange: OTC MARKETS
Currency:
USD
Asset
Type: Common Stock
CIK:0000912544
Company Profile
novelstem international corp. focuses on developing and commercialization of diagnostic technology that can predict patients' resistance to chemotherapy allowing for targeted cancer treatments and the potential to reduce resistance to chemotherapy. it has a collaboration agreement with newstem ltd. for stem-cell technology platform in cancer immunotherapy and covid-19 resistance. the company was formerly known as hollywood media corp. and changed its name to novelstem international corp. in september 2018 as a result of its business focus shift from advertising services to stem cell-based diagnostics for cancer chemotherapies. the company was founded in 1993 and is headquartered in boca raton, florida.
Sector: Retail Trade
Industry: Electronic Shopping
Standard Industrial Classification Code (SIC code): 5990
Address: N/A
Website: N/A
CEO: N/A
Tags:
- Biotechnology
- Health Technology
Pricing
Last Updated: December 31, 1969 07:00 PM EST
Previous Close: -
Change:
-$0.05
(
-24.76%)
Days Range: $0.13 - $0.19
Beta: -
52wk. High: $0.27
52wk. Low: $0.11
Ytd. Change -29.44%
50 Day Moving Average: $0.19
200 Day Moving Average: $0.21
Shares Outstanding: 46881475
Valuation
Market Cap: 839.2M
PE Ratio: -
EPS (TTM): 0
Dividends
Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A